Research Article
Neutrophil-to-Lymphocyte Ratio and Albumin: New Serum Biomarkers to Predict the Prognosis of Male Alcoholic Cirrhosis Patients
Table 2
Baseline demographics and clinical characteristics of patients in the surviving and nonsurviving groups.
| | Variables | Surviving () | Nonsurviving () | value |
| | Basic demographics | | | | | Age | 51 (45-58) | 50 (43-59) | 0.25 | | Alcohol intake (g/day) | 160 (125-250) | 200 (125-250) | 0.89 | | Duration of drinking (years) | 27 (20-30) | 25 (20-30) | 0.99 | | Clinical features | | | | | Anorexia and epigastric discomfort | 59 (19.3) | 7 (17.5) | 1.00 | | Fatigue | 134 (43.9) | 18 (45.0) | 1.00 | | Abdominal distension | 172 (56.4) | 29 (72.5) | 0.06 | | Jaundice | 122 (40.0) | 18 (45.0) | 0.61 | | Edema | 108 (35.4) | 13 (32.5) | 0.86 | | Child-Pugh A | 23 (7.5%) | 1 (2.5%) | 0.34 | | Child-Pugh B | 114 (37.4%) | 5 (12.5%) | 0.001 | | Child-Pugh C | 168 (55.1%) | 34 (85.0%) | <0.001 | | Complications | | | | | Hepatic encephalopathy | 42 (13.8) | 18(45.0) | <0.001 | | Ascites | 232 (76.1) | 31(77.5) | 1.00 | | Gastrointestinal hemorrhage | 61 (20.0) | 10 (25.0) | 0.53 | | HCC | 8 (2.6) | 1 (2.5) | 1.00 | | Laboratory data | | | | | AST (U/L) | 60.3 (36.0-104.0) | 66.0 (35.0-117.6) | 0.43 | | ALT (U/L) | 30.8 (22.0-47.0) | 30.0 (16.0-52.0) | 0.44 | | ALP (U/L) | 114.0 (83.9-156.0) | 108.9 (86.0-150.0) | 0.46 | | GGT (U/L) | 100.8 (45.0-317.6) | 64.0 (31.0-186.0) | 0.14 | | ALB (g/L) | 26.9 (23.3-31.3) | 24.1 (18.8-25.8) | 0.001 | | TBIL(μmol/L) | 61.6 (31.0-131.0) | 173.3 (72.1-315.8) | <0.001 | | PLT (×109/L) | 87.0 (55.0-140.0) | 79.0 (55.0-125.0) | 0.63 | | PT (s) | 15.0 (13.4-18.1) | 20.2 (15.0-22.8) | <0.001 |
|
|
